For 2019, there were no reported cases of yellow fever in the EU/EEA.

Annual Epidemiological Report for Zoonotic influenza, 2014

No human cases of avian influenza were reported in the EU/EEA. Sporadic cases were reported from Africa and Asia.

In 2014, a total of 16 cases of anthrax was reported by four EU/EEA countries. One case was reported as a confirmed case. The remaining 26 reporting countries notified zero cases.

For 2017, EU/EEA countries reported one case of yellow fever. The travel-related case was reported by the Netherlands with exposure in Suriname.

For 2018, one case of travel-related rabies with exposure in Morocco was reported by the United Kingdom.

Carbapenem resistance in Enterobacteriaceae such as Klebsiella pneumoniae and Escherichia coli poses a significant threat to patients and healthcare systems in all European Union/European Economic Area (EU/EEA) countries. Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of treatment options.

This report is based on data for 2015 retrieved from The European Surveillance System (TESSy) on 12 December 2016.

Influenza activity started in week 45/2019 and returned to baseline levels in week 13/2020, earlier than previous seasons. Influenza viruses circulated at high levels between weeks 52/2019 and 10/2020 (based on increased proportions (40% and above) of sentinel specimens testing positive for influenza viruses). This is comparable to previous seasons.

This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.